Sinopharm: its subsidiary obtained overseas registration certificate for API
Financial Associated Press, Dec. 14, Sinopharm announced that its wholly-owned subsidiary Sinopharm Rongsheng potassium chloride injection (10ml: 1.5g) obtained the notice of approval for drug supplement application and approved to increase the specification of 10ml: 1.5g. Its wholly-owned subsidiary Sinopharm Wichita obtained the registration certificate of lipoic acid API issued by the Ministry of health and family welfare of India and the Ministry of food and drug safety of South Korea respectively.
This text is a result of machine translation.
Related companies：
Briefing Aug 01, 2022 03:11 PM
· Healthcare
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
In-depth
Briefing Jul 29, 2022 11:42 AM
· Technology
IC Design Company Yuntu Harvests Hundreds of Mns of CNY in Series A+
Aug 09, 2022 04:42 PM
May 02, 2022 07:50 PM
Apr 26, 2022 12:26 PM
Apr 21, 2022 07:07 PM
Briefing Jun 28, 2022 04:29 PM
· Healthcare
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Briefing Feb 20, 2022 03:39 PM
· Technology
Aladdin energy group's strategic investment in southern power grid energy under China Southern Power Grid
See more
Read next
Insight
In-depth
Healthcare
Digital Therapeutics Series Report - Digital Revolution in Healthcare
Updated 10 hours ago
Insight
In-depth
Insight
In-depth